MENU
+Compare
IKNA
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$1.55
Change
-$0.07 (-4.32%)
Capitalization
78.18M

IKNA Ikena Oncology Forecast, Technical & Fundamental Analysis

Industry Biotechnology
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for IKNA with price predictions
Dec 17, 2024

IKNA's RSI Indicator climbs out of oversold territory

The RSI Indicator for IKNA moved out of oversold territory on December 17, 2024. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In of the 22 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where IKNA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IKNA advanced for three days, in of 168 cases, the price rose further within the following month. The odds of a continued upward trend are .

IKNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 05, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on IKNA as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IKNA turned negative on November 15, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

IKNA moved below its 50-day moving average on December 03, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IKNA crossed bearishly below the 50-day moving average on November 26, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IKNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IKNA entered a downward trend on December 17, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.557) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). IKNA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (113.636) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. IKNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IKNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IKNA is expected to report earnings to fall 1.57% to -20 cents per share on March 18

Ikena Oncology IKNA Stock Earnings Reports
Q4'24
Est.
$-0.21
Q3'24
Beat
by $0.04
Q2'24
Beat
by $0.08
Q1'24
Beat
by $0.07
Q4'23
Beat
by $0.01
The last earnings report on November 07 showed earnings per share of -20 cents, beating the estimate of -25 cents. With 96.60K shares outstanding, the current market capitalization sits at 78.18M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
645 Summer Street
Phone
+1 857 273-8343
Employees
43
Web
https://www.ikenaoncology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FUTU86.183.73
+4.52%
Futu Holdings Limited
TLRY1.240.04
+3.33%
Tilray Brands
OMEX0.340.01
+1.90%
Odyssey Marine Exploration
NFLX919.13-1.95
-0.21%
Netflix
OABI3.76-0.03
-0.79%
OmniAb

IKNA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been closely correlated with ABCZF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IKNA jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
+0.62%
ABCZF - IKNA
72%
Closely correlated
N/A
ATRA - IKNA
72%
Closely correlated
-1.52%
AMLX - IKNA
54%
Loosely correlated
+2.39%
VNDA - IKNA
37%
Loosely correlated
+2.16%
FATE - IKNA
35%
Loosely correlated
-6.00%
More

Groups containing IKNA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
+0.62%
IKNA
(3 stocks)
15%
Poorly correlated
-3.20%